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Abstract
Both the B cell antigen receptor (BCR) signaling and Notch signaling pathway play important roles in marginal zone (MZ) B
cell development; however, if and how these two signaling pathways engage in crosstalk with each other remain unclear. In
the present study, IgH transgenic mice (TgVH3B4) were crossed with mice with Notch downstream transcription factor RBP-J
floxed alleles (RBP-J
f/f) and Mx-Cre transgene. Subsequently, MZ B cell development was analyzed in 3B4/Cre/RBP-J
f/f mice
that expressed the transgenic 3B4 IgH and exhibited a deficiency in Notch signaling in B cells upon poly (I:C) injection. We
observed that MZ B cell numbers were severely reduced, but still detectable in 3B4/Cre/RBP-J
f/f mice, in contrast to
increased numbers of MZ B cells in TgVH3B4 mice and almost no MZ B cells in Cre/RBP-J
f/f mice. The majority of the MZ B
cells in the 3B4/Cre/RBP-J
f/f mice had the same antigen specificity with that of 3B4 antibody, indicating that a particular BCR
specificity might direct MZ B cell development in the absence of Notch signaling. The number of MZ B precursor (MZP) cells
was reduced sharply in 3B4/Cre/RBP-J
f/f mice, and the number of transitional stage 1 and transitional stage 2 cells did not
change that much, indicating that the interaction between BCR and Notch signaling likely occurred during the T2-MZP
stage. Based on the transgenic mouse model, our data indicate that MZ B cells with certain BCR specificity can develop in
a Notch-RBP-J independent manner.
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Introduction
Marginal zone (MZ) B cells are a separate B cell lineage distinct
from mature follicular (FO) B cells and B-1 cells, and are critical
determinants of the host defense against blood-borne bacterial
pathogens [1,2]. MZ B cells reside in the outer white pulp of the
spleen between the marginal sinus and the red pulp; they are
identified as being CD21
hiCD23
low CD9
+CD1d
hiIgD
lowIgM
hi
[3,4]. MZ B cells are generated as naı ¨ve B cells that intrinsically
possess several properties that resemble those of memory B cells,
including a pre-activated phenotype and the ability to self-renew
and survive for the duration of the life span of the host [1,2,5].
The mechanisms underlying MZ B cell development remains
unclear. B cells undergo a series of differentiation checkpoints
before they become mature functional antibody-secreting cells
[6,7]. After B lineage commitment, progenitor B cells (pro-B)
begin to rearrange their B cell antigen receptor (BCR) genes at the
VH loci and differentiate into precursor B (pre-B) cells [8]. Next,
pre-B cells undergo a second round of BCR rearrangement at the
VL loci to generate immature B cells that possess a functional BCR
[9]. These immature B cells next undergo negative selection,
during which B cell clones that respond to self-antigens are cleared
through apoptosis, anergy, or receptor editing [10–12]. Immature
B cells that are weakly or not self-reactive mature further. Newly
generated B cells that have yet to acquire the ability to recirculate
are known as transitional stage 1 (T1) B cells. Upon entering the
follicles, these cells acquire surface IgD and CD23 expression
while maintaining the expression of markers of immaturity. These
cells are considered transitional stage 2 (T2) B cells [13,14]. T2 B
cells then differentiate directly into FO B cells or pass through the
T2-MZ B cell progenitor (MZP) stage into the MZ B cell
compartment [2].
Several signaling pathways triggered by cell surface receptors
are required for MZ B cell development, including BCR signaling
[15–17], Notch signaling [18,19], canonical and non-canonical
NF-kB signaling [20,21], and BAFFR signaling [22–24]. BCR
signaling is the fundamental driving force for MZ B cell
development. It has been well documented that weak BCR
signaling leads B cells to develop into MZ B cells. For example,
mutations of molecules that attenuate BCR signaling, such as
Aiolos or CD22, result in an increased number of FO B cells, while
MZ B cells are absent [25,26]. Conversely, deficiencies in
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deficiency, increase the number of MZ B cells [25]. Additionally,
increased Btk signaling promotes FO B cell development, while
weakening of this signaling pathway promotes MZ B cell
development [2]. Certain BCR specificities also drive MZ B cell
development. In VH81X transgenic mice, B cells differentiate into
MZ B cells, while in anti-hen egg lysozyme and anti-class I MHC
transgenic mice, B cells differentiate into FO B cells [27,28].
However, it has been suggested that once a cell has been selected
to become a FO B cell or a MZP B cell based on BCR specificity
and signaling strength, further development into a mature FO or
a MZ B cell, respectively, does not occur by default [29]. Signaling
from other pathways, such as Notch2-mediated signaling, is
required for MZ B cell generation.
The mammalian Notch family consists of four highly conserved
transmembrane receptors that regulate cell fate determination in
various tissues [30]. Ligand binding to Notch receptors leads to
proteolytic processing within the transmembrane domains and the
subsequent release of the intracellular domain [31,32]. The Notch
intracellular domain then translocates into the nucleus, where it
forms a ternary complex with RBP-J/CBF1 (the vertebrate
homolog of Suppressor of Hairless) and Mastermind, a transcrip-
tional coactivator, to mediate gene transcription activation [33].
The role of Notch signaling in the development of MZ B cells has
been firmly established. When RBP-J is conditionally deleted in B
cells, MZ B cells are absent and FO B cell numbers are enhanced
[18]. Also, conditional knockout studies revealed that Delta-like1
(Dll1) [19], Notch2 [34] and Mastermind-like (MAML) proteins
are all required for MZ B cell development.
Although both BCR and Notch signaling pathways are required
for MZ B cell development, if and how these two signaling
pathways interact with each another remains unknown. Pre-
viously, we generated IgH transgenic mice TgVH3B4 with the VH
derived from the natural autoantibody producing hybridoma 3B4.
These mice exhibited an increased proportion of MZ B cells
[35,36]. In the present study, TgVH3B4 mice, transgenic mice
containing a floxed allele of RBP-J (RBP-J
f/f) and Mx-Cre mice
were crossed to obtain mice that have the transgenic IgH, but
deficient in Notch signaling in B cells following the conditional
deletion of RBP-J. The results demonstrated that there were
increased numbers of MZ B cells in TgVH3B4 mice and almost no
MZ B cells in Cre/RBP-J
f/f mice. In 3B4/Cre/RBP-J
f/f mice,
although MZ B cell numbers were substantially reduced, MZ B
cells were still detectable. The majority of the MZ B cells in the
3B4/Cre/RBP-J
f/f mice had the same antigen specificity with that
of 3B4 antibody, indicating that the abrogation of Notch-RBP-J
signaling in B cells can attenuate BCR-directed MZ B cell
development, likely by reducing BCR diversity.
Results
Abrogation of Notch signaling attenuated MZ B cell
development in IgH transgenic mice
To induce the deletional inactivation of RBP-J through Cre
expression in the IgH transgenic mice TgVH3B4, mice containing
the floxed RBP-J allele were bred with TgVH3B4 mice and Mx-
Cre transgenic mice in which Cre recombinase expression is
transactivated by the Mx promoter after the IFN-a inducer ploy
(I:C) injection [37]. Mice with the Cre/RBP-J
f/+, 3B4/Cre/RBP-
J
f/+, Cre/RBP-J
f/f and 3B4/Cre/RBP-J
f/f genotypes were ana-
lyzed after the injection of poly (I:C). Consistent with a previous
report [37], deletion of the RBP-J allele was nearly 100% in the
bone marrow (BM) and approximately 80% in the spleen as
confirmed using Southern blot analysis (data not shown).
Next, we analyzed B cell development in the spleen following
RBP-J deletion. Anti-CD19, anti-CD21 and anti-CD23 antibodies
were used to discriminate between FO B (CD19
+CD21
intCD23
hi)
and MZ B (CD19
+CD21
hiCD23
lo) cells. Consistent with previous
results [35,36], we observed an increased proportion of MZ B cells
in 3B4/Cre/RBP-J
f/+ mice, which was predominately due to
decreased FO B cell production (Figure 1). Also in agreement with
earlier findings, the MZ B cell proportion was significantly
reduced in the Cre/RBP-J
f/f mice because of the abrogated Notch
signaling (Figure 1) [18]. Interestingly, the population of MZ B
cells in the 3B4/Cre/RBP-J
f/f mice was greatly reduced compared
with the 3B4/Cre/RBP-J
f/+ mice; however, the proportion of MZ
B cells in 3B4/Cre/RBP-J
f/f mice was still much higher compared
with the Cre/RBP-J
f/f mice (Figure 1). There was no difference in
phenotype between wild-type and the Cre/RBP-J
f/+ mice. These
data indicate that abrogation of Notch signaling attenuated but
not abrogated the MZ B cell differentiation in 3B4 IgH transgenic
mice.
A small population of MZ B cells exist in the absence of
RBP-J in IgH transgenic mice
BM transplantation was utilized to further analyze the MZ B
cell development. This methodology was selected because
poly(I:C) injection induced the non-specific activation of many
cell types; further, the deletion efficiency of the RBP-J allele only
reached 80% in the spleen following poly(I:C) injection. Two
months after BM transplantation, southern blot was applied to
analyze the DNA from the BM and spleen of the recipient mice.
The result showed that the RBP-J allele was deleted completely in
both BM and spleen after BM transplantation (Figure 2F). Then
the recipient mice were sacrificed and spleen cells were prepared
for flow cytometric (FCM) analysis. As described previously, there
were elevated frequency of MZ B cells in 3B4/Cre/RBP-J
f/+ mice;
further, we observed almost no MZ B cell subset in Cre/RBP-J
f/f
mice (Figure 2A). Although the proportion of MZ B cells was
significantly decreased in 3B4/Cre/RBP-J
f/f mice, it was higher
compared with Cre/RBP-J
f/f mice (Figure 2A). When analyzed
using anti-CD21 and anti-CD24 antibodies, similar results were
obtained. While the proportion of CD21
hiCD24
hi MZ/T2 cells
was elevated in 3B4/Cre/RBP-J
f/+ mice and significantly reduced
in Cre/RBP-J
f/f mice, the frequency of MZ/T2 cells in 3B4/Cre/
RBP-J
f/f mice was lower than 3B4/Cre/RBP-J
f/+ mice and higher
than Cre/RBP-J
f/f mice (Figure 2B). In agreement with flow
cytometric data, histological examination of the spleen showed the
loss of MZB cells in Cre/RBP-J
f/+ mice and 3B4/Cre/RBP-J
f/f
mice by staining of the MOMA-1
+ metalophilic macrophages that
define the border between the MZ B and FO B cells (Figure 2E).
This defect was observed in all follicles of the mice.
The total numbers of FO and MZ B cells were estimated from
FCM profiles and the total number of CD19
+ cells (Figure 2C). In
3B4/Cre/RBP-J
f/+ mice, we observed a four- to five-fold decrease
in the number of FO B cells, while the MZ B cell numbers
remained unchanged. In Cre/RBP-J
f/f mice, we observed a slight
increase in FO B cell numbers and MZ B cells were almost absent.
However, in 3B4/Cre/RBP-J
f/f mice, both FO and MZ B cell
numbers were reduced; importantly, the number of MZ B cells in
3B4/Cre/RBP-J
f/f mice was still elevated compared with Cre/
RBP-J
f/f mice. The ratio of MZ B cells to FO B cells was estimated
from the above data (Figure 2D). These results indicated that MZ
B cells were relatively elevated in 3B4/Cre/RBP-J
f/+ mice and
were reduced in Cre/RBP-J
f/f mice. The proportion of MZ B cells
remained at a normal level in 3B4/Cre/RBP-J
f/f mice. Taken
together, these data suggested that Notch signaling is required for
MZ B cell development in mice with or without transgenic IgH;
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independent of Notch signaling in IgH transgenic mice.
MZ B cells in 3B4/Cre/RBP-J
f/f mice had identical antigen
specificity
To explore the features of the MZ B cells in the absence of
Notch signaling, we analyzed the antigen specificity of the MZ B
cells in 3B4/Cre/RBP-J
f/f mice. As we did not have access to an
idiotype-specific antibody against the monoclonal 3B4 antibody,
we utilized FITC-conjugated actin to analyze BCR specificity
[36], as the antibodies from the 3B4 hybridoma bind actin. The
flow cytometry data shown in Figure 3A is the proportion of MZ B
and FO B cells gated from actin-positive cells of spleen. Absolute
number of actin-bound MZ B cells was then calculated and
divided by total MZ B cells to get the data shown in Figure 3B, the
percentage of MZ B cells that bound actin. The results showed
that the majority of the MZ B cells in 3B4/Cre/RBP-J
f/f mice
bound actin, while in 3B4/Cre/RBP-J
f/+ mice only approximately
10% of MZ B cells bound actin (Figure 3A and B). Similar results
were obtained when keratin-FITC and myosin-FITC were used to
analyze the antigen specificity of the MZ B cells, as 3B4 antibody
can also bind these two antigens (data not shown). These results
indicated that only MZ B cells with certain antigen specificity
could survive the Notch deficiency, and Notch signaling may affect
MZ B cell development by interfering with BCR signaling.
Integration of BCR and Notch signaling occurs at the T2-
MZP stage
We next sought to determine the developmental stage during
which BCR and Notch signaling interact to influence MZ B cell
development. To discriminate between T1, T2, MZP, FO and
MZ B cells, we analyzed splenic B cell surface expression of IgM,
CD21 and CD23. We found that the number of T1 (CD23
2IgM-
hiCD21
lo) cells was decreased by approximately one-fold in 3B4/
Cre/RBP-J
f/+ mice and 3B4/Cre/RBP-J
f/f mice compared with
the Cre/RBP-J
f/+ mice and Cre/RBP-J
f/f mice (Figure 4A and B).
These results are consistent with the data in Figure 2B, in which
CD21 and CD24 surface expression was utilized for analysis.
There was also a slight reduction in the number of T2
(CD23
+IgM
hiCD21
int) cells in 3B4/Cre/RBP-J
f/+ mice and
3B4/Cre/RBP-J
f/f mice compared with the other two groups
(Figure 4A and B). Interestingly, the greatest reduction occurred at
the MZP (CD23
+IgM
hiCD21
hi) stage. In the Cre/RBP-J
f/f mice
and 3B4/Cre/RBP-J
f/f mice, the number of MZP B cells was less
than one fifth of that in the Cre/RBP-J
f/+ and 3B4/Cre/RBP-J
f/+
mice (Figure 4A and B). 3B4/Cre/RBP-J
f/f mice possessed more
MZP cells than Cre/RBP-J
f/f mice. However, there was no
difference in the number of MZP B cells between Cre/RBP-J
f/+
and 3B4/Cre/RBP-J
f/+ mice. These data indicated that in 3B4/
Cre/RBP-J
f/+ mice, the biased development to MZ B cells began
at the T2-MZP stage, after this point the development of FO B
cells was interrupted while MZP and MZ B cell differentiation
remained intact. In Cre/RBP-J
f/f mice, the effects of Notch-RBP-J
deficiency may also begin at the T2-MZP stage, resulting in the
marked reduction of MZP and MZ B cell numbers. In 3B4/Cre/
RBP-J
f/f mice, while the number of both T2 cells and MZP cells
was decreased, the number of MZP and MZ B cells was doubled
compared with Cre/RBP-J
f/f mice, indicating that abrogation of
Notch signaling may interfere with BCR-directed MZ B cell
development at the T2-MZP stage.
Analysis of BM B cell development
We also analyzed B cell development in the BM following the
deletion of the RBP-J allele. When analyzed using anti-CD43,
anti-IgM and anti-B220 antibodies to discriminate pro-B
(IgM
2B220
+CD43
+) and pre-B (IgM
2B220
+CD43
2) cells, we
found a slightly elevated proportion of pro-B cells in Cre/RBP-J
f/f
mice and 3B4/Cre/RBP-J
f/f mice compared with Cre/RBP-J
f/+
mice and 3B4/Cre/RBP-J
f/+ mice, indicating that the absence of
Notch signaling promote pro-B cells production (Figure 5A).
Consistent with our previous study, pre-B cell population in 3B4/
Cre/RBP-J
f/+ mice were decreased to less than one half of the
other three strains of mice [36]; this decrease was predominately
due to the aberrant paring of the m chain with the surrogate light
chain to form pre-BCR (Figure 5A). However, there was no
decrease in the proportion of pre-B cells in the 3B4/Cre/RBP-J
f/f
mice, indicating that the abrogation of Notch signaling may help B
cells to pass through the pre-BCR checkpoint. To analyze newly
formed immature B cells (CD23
2IgM
+B220
+), CD23
2 cells were
gated and subsequently identified using anti-IgM and anti-B220
antibodies. We observed a marked reduction in the number of
immature B cells in 3B4/Cre/RBP-J
f/+ mice; further, no
differences between Cre/RBP-J
f/+, Cre/RBP-J
f/f and 3B4/Cre/
RBP-J
f/f mice were noted (Figure 5B). Our data suggests that when
Figure 1. Analysis of MZ and FO B cells following Mx-Cre-induced RBP-J deletion. Mice with genotypes of Cre/RBP-J
f/+, 3B4/Cre/RBP-J
f/+,
Cre/RBP-J
f/f and 3B4/Cre/RBP-J
f/f were compared. Deletion of the floxed RBP-J exons was induced through the injection of poly(I:C); mice were then
sacrificed and subjected to MZ and FO B cell analysis by FCM. The cells were first gated by anti-CD19 and then CD21 and CD23 expression was
utilized to discriminate between FO (CD19
+CD21
intCD23
hi) and MZ B (CD19
+CD21
hiCD23
lo) cells. The numbers denote the percentages of cells in the
indicated squares. Data are representative of five independent experiments.
doi:10.1371/journal.pone.0038894.g001
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38894Figure 2. Analysis of MZ and FO B cells following BM transplantation. (A) and (B) Two months following BM transplantation, the four groups
of mice were sacrificed and spleen cells were stained using anti-CD19, anti-CD21 and anti-CD23 (A), or anti-CD19, anti-CD21 and anti-CD24 (B) and
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overcome the developmental block in the BM of 3B4/Cre/RBP-
J
f/f mice.
Discussion
The aim of the present study was to explore the integration of
BCR and Notch signaling in MZ B cell development. B cell
development in mice with a transgenic IgH that lack Notch
signaling was analyzed by using IgH transgenic mice TgVH3B4,
RBP-J-floxed mice and Mx-Cre mice. Our data indicated that the
elevated population of MZ B cells observed in TgVH3B4 mice was
greatly reduced following abrogation of Notch signaling in 3B4/
Cre/RBP-J
f/f mice. These finding were consistent with those
obtained from Cre/RBP-J
f/f mice, and indicated that Notch
signaling is required for BCR-directed MZ B cell development.
However, in contrast to Cre/RBP-J
f/f mice, a small number of
MZ B cells that escaped the Notch-RBP-J checkpoint were
observed in 3B4/Cre/RBP-J
f/f mice. Further analysis of the BCR
specificity of these remaining MZ B cells indicated that these cells
exhibited identical antigen specificity derived from the original
3B4 antibody. These data suggested that certain B cells with
particular BCR specificity can develop into MZ B cells without
Notch signaling. Our study revealed for the first time that MZ B
cells can develop in a Notch-independent manner.
Both the BCR and Notch signaling pathways play important
roles in B cell development, activation, and lymphomagenesis.
However, if and how the BCR and Notch signaling pathways
interact with each other remains unclear. Several studies reported
that BCR and Notch signaling cooperated to promote B cell
activation. He et al. used a soluble human Dll1 fragment and anti-
IgM to stimulate Burkitt’s lymphoma Raji cells and found that
Notch signaling may interact with BCR signaling at the level of c-
myc expression to regulate B-lymphoma cell proliferation and
apoptosis [38]. Thomas et al. demonstrated that costimulation of
follicular B cells with Dll1 leads to significant increases in BCR-
and CD40-mediated proliferation and enhances production of
IgG1-positive cells in vitro and in vivo; taken together, these data
suggest that the BCR and CD40 signaling pathways collaborate
with the Notch pathway to optimize B cell activation [39].
However, the interaction between BCR and Notch signaling in
MZ B cell development remains unclear.
Pillai et al. proposed that strong BCR signaling activates
Bruton’s tyrosine kinase, which inhibits Notch2 signaling and
activates the canonical NF-kB signaling pathway, subsequently
promoting FO B cell development [29]. During MZ B cell
development, weak BCR signaling permits Notch2 signaling. The
interaction of Dll1 with Notch2 leads to the activation of MAML1
and RBP-J and MZ B cell development [29]. Pillai hypothesized
that Notch2 signaling is the primary driving force for MZ B cell
development, and that BCR signaling affects MZ B cell de-
velopment by interfering with the Notch pathway. However, our
study suggested that BCR signaling may be the primary driving
force for MZ B cell development, and that Notch signaling may
affect the BCR pathway to alter the direction of B cell
development. The helix-loop-helix transcription factor E2A is an
important candidate molecule that might link the BCR and Notch
signaling pathways. E2A
+/2 mice exhibited increased MZ B cell
development at the expense of FO B cell development [40].
Interestingly, Notch signaling can cause the degeneration of both
E2A isoforms (E12 and E47) and may therefore contribute to MZ
B cell development by regulating the availability of the E12 and
E47 transcriptional regulators [41]. More studies are needed to
elucidate the detailed mechanisms underlying BCR and Notch
interactions.
Although Notch has long been known to regulate MZ B cell
development, the stage at which Notch signaling exerts its effects is
unknown. The ligand for Notch2, Dll1, is expressed on the luminal
face of venules that are predominately found in the red pulp of the
spleen, and some Dl1 expression is also present in the MZ [42].
Thus, Notch signaling would be activated when B cells migrate
from blood vessels to the MZ or when B cells shuttle between the
follicles and the MZ. Our data indicate that the reduction of MZ B
cells begins at the T2-MZP stage, indicating that the function of
Notch and the interaction between BCR signaling and Notch
signaling likely occurred during the T2-MZP stage. This
hypothesis is consistent with the finding that T2 B cells are the
common precursor of both FO and MZ B cells prior to
differentiation [2].
Analysis of BM B cell development revealed a slightly elevated
numbers of pro-B cells in Cre/RBP-J
f/f mice and 3B4/Cre/RBP-
J
f/f mice, which is different with that of CD19-Cre/RBP-J
f/f mice
[18]. The reason may be that Mx-Cre induces complete deletion
of RBP-J allele before the pro-B cell satge, while CD19-Cre only
partially induces the RBP-J deletion at the pro- and pre-B cell
stage. Consistent with previous reports, we also observed reduced
numbers of pre-B cells in 3B4/Cre/RBP-J
f/+ mice, a finding that
may be due to the aberrant paring of the m chain with the
surrogate light chain to form the pre-BCR. In the BM, appropriate
pairing of the m chains with surrogate light chains to form the pre-
BCR is critical for B cell development prior to surface IgM
expression at the pre-B cell stage [43–45]. However, the number
of pre-B cells in 3B4/Cre/RBP-J
f/f mice is normal compared with
Cre/RBP-J
f/+ mice, indicating that the absence of Notch signaling
might promote pre-B cell development at the pre-BCR check-
point.
Materials and Methods
Ethics Statements
The animal husbandry, experiments and welfare were con-
ducted in accordance with the Detailed Rules for the Adminis-
tration of Animal Experiments for Medical Research Purposes
issued by the Ministry of Health of China, and were approved by
the Animal Experiment Administration Committee of Fourth
Military Medical University. Mice were raised in the specific
pathogen free conditions on the C57BL/6 background, and were
manipulated with every specific care to reduce the suffering of the
mice during the experiments.
then analyzed using FCM. The cells were initially gated using anti-CD19. CD24
hiCD21
hi cells represent MZ/T2 B cells, and CD21
medCD24
hi cells
represent T1 cells. The numbers denote the percentages of cells in the indicated squares. Data are representative of five independent experiments.
(C) Absolute numbers of MZ and FO B cells. Numbers were calculated by multiplying the fraction of each FCM B cell subset analyzed in (A) by the
total number of CD19
+ cells. Data are mean6S.D. obtained from five independent experiments. (D) The ratio of MZ to FO cell number was calculated.
(E) Immunofluorescent staining of splenic cryosections with Cy3-anti-IgM and FITC-anti–MOMA-1. MOMA-1
+ metalophilic macrophages define the
border between the MZ B and FO B cells. Data are representative of five independent experiments. Scale bar, 100 mm. (F) Southern blot analysis of
the DNA from the BM and spleen of the recipient mice. 4 Kb fragment represents wild-type, and 3 Kb fragment represent deletion.
doi:10.1371/journal.pone.0038894.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38894Figure 3. BCR specificity analysis of B cells in the spleen. (A) FITC-conjugated actin in combination with anti-CD21 and anti-CD23 antibodies
was used to analyze the antigen specificity of MZ and FO B cells by FCM following BM transplantation. The cells were first gated by actin staining and
then analyzed according to CD21 and CD23 expression. (B) The percentage of actin-reactive MZ B cells within the total MZ B cell population is shown.
Data are representative of five independent experiments.
doi:10.1371/journal.pone.0038894.g003
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IgH transgenic mice TgVH3B4 were generated in our lab; line
#39 was utilized in this study because of its high allelic exclusion
[35,36]. RBP-J-floxed mice and Mx-Cre mice have been described
previously [37]. TgVH3B4 mice were crossed with Mx-Cre/RBP-
J
f/f mice for at least two generations to obtain mice with the
genotypes of Cre/RBP-J
f/+, 3B4/Cre/RBP-J
f/+, Cre/RBP-J
f/f
and 3B4/Cre/RBP-J
f/f. The transgenic mice were genotyped
using PCR as described previously.
Deletion of the RBP-J gene through Cre-mediated
recombination
Mice with genotypes of Cre/RBP-J
f/+, 3B4/Cre/RBP-J
f/+,
Cre/RBP-J
f/f, 3B4/Cre/RBP-J
f/f and wild-type were employed in
the current study. To induce the Cre-mediated deletion of the
RBP-J gene, 6- to 8-week-old mice were injected i.p. with 300 mg
of poly(I:C) (Sigma, St. Louis) for four times at two-day intervals.
Mice were then injected with the same amount of poly(I:C) for
four additional times at one-week intervals; in total, mice were
given eight injections. Two days following the last injection, the
mice were sacrificed for further analysis. Southern blot analysis
was utilized to determine the deletion efficiency of the RBP-Jk
allele as described previously [37].
BM transplantation
BM cells were prepared from mice injected with poly(I:C).
Recipients were irradiated with 8 Gy and then i.v. injected with
2610
6 donor BM cells through the tail vein. Mice were
maintained on aqueous antibiotics (1.1 g/L of neomycin sulfate)
and analyzed after 2 months.
Figure 4. Analysis of transitional B cells in the spleen. (A) Splenocytes were stained with antibodies specific for CD21, CD23 and IgM, and
subjected to FCM analysis. CD23
2 (A) and CD23
+ (B) populations were gated separately and analyzed according to CD21 and IgM expression. Cell
populations were defined using the following markers: T1 cells, CD23
2IgM
hiCD21
2; T2 B cells, CD23
+IgM
hiCD21
+; MZP cells, CD23
+IgM
hiCD21
hi;M ZB
cells, CD23
2IgM
hiCD21
hi; and FO B cells, CD23
+IgM
loCD21
lo. The numbers denote the percentages of cells in the indicated squares. Data are
representative of five independent experiments. (B) The absolute numbers of splenic T1, T2 and MZP B cells were calculated from the FCM data in (A)
and the total number of erythrocyte-depleted splenocytes. Data represent the mean6S.D. from five independent experiments.
doi:10.1371/journal.pone.0038894.g004
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Cells were collected from mouse tissues and treated with
buffered 0.14 M NH4Cl. Cells (5610
5) were stained with
antibodies for 30 min on ice and analyzed using a FACSCalibur
TM
(BD Immunocytometry Systems, San Jose, CA). Data were
analyzed using Cellquest
TM software. Dead cells were excluded
using propidium iodide staining. The antibodies used in the
analyses were as follows: anti-B220 (RA3-6B2), anti-IgM (R6-
60.2), anti-CD5 (53–7.3), anti-CD19 (1D3), anti-CD21/35 (7G6),
anti-CD23 (B3B4), anti-CD24 (M1/69), anti-CD43 (S7), and
streptavidin-APC. All antibodies were obtained from BD Phar-
Mingen (San Diego, CA). FITC-conjugated actin was prepared
according to standardized methods.
Immunofluorescent staining of tissue sections
Tissue samples from spleens were frozen in tissue-tek OCT
compound and cut at a thickness of 6 mm. After air-drying,
sections were fixed in 4% paraformaldehyde for 20 min.
Immunohistochemical staining was done with Cy3-anti–mouse
IgM and FITC-anti–MOMA-1 (Serotec) antibodies for 1 h at
room temperature. Slides were analyzed with a laser scanning
confocal microscope (OLYMPUS FluoView
TM FV1000).
Data analysis
ANOVA was used to determine the statistical significance of
values among experimental groups. The statistical significance was
defined as p,0.05.
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